280 related articles for article (PubMed ID: 12966163)
1. Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking.
Trejo J
J Pharmacol Exp Ther; 2003 Nov; 307(2):437-42. PubMed ID: 12966163
[TBL] [Abstract][Full Text] [Related]
2. Cofactoring and dimerization of proteinase-activated receptors.
Lin H; Liu AP; Smith TH; Trejo J
Pharmacol Rev; 2013; 65(4):1198-213. PubMed ID: 24064459
[TBL] [Abstract][Full Text] [Related]
3. Endosomal signaling by protease-activated receptors.
Grimsey N; Lin H; Trejo J
Methods Enzymol; 2014; 535():389-401. PubMed ID: 24377935
[TBL] [Abstract][Full Text] [Related]
4. How the protease thrombin talks to cells.
Coughlin SR
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11023-7. PubMed ID: 10500117
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells.
Greenberg DL; Mize GJ; Takayama TK
Biochemistry; 2003 Jan; 42(3):702-9. PubMed ID: 12534282
[TBL] [Abstract][Full Text] [Related]
6. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulation of protease-activated receptor signaling.
Canto I; Soh UJ; Trejo J
Mini Rev Med Chem; 2012 Aug; 12(9):804-11. PubMed ID: 22681248
[TBL] [Abstract][Full Text] [Related]
8. Differential signaling by protease-activated receptors: implications for therapeutic targeting.
Sidhu TS; French SL; Hamilton JR
Int J Mol Sci; 2014 Apr; 15(4):6169-83. PubMed ID: 24733067
[TBL] [Abstract][Full Text] [Related]
9. Protease activated receptors: theme and variations.
O'Brien PJ; Molino M; Kahn M; Brass LF
Oncogene; 2001 Mar; 20(13):1570-81. PubMed ID: 11313904
[TBL] [Abstract][Full Text] [Related]
10. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells.
Colognato R; Slupsky JR; Jendrach M; Burysek L; Syrovets T; Simmet T
Blood; 2003 Oct; 102(7):2645-52. PubMed ID: 12805069
[TBL] [Abstract][Full Text] [Related]
12. The domino effect triggered by the tethered ligand of the protease activated receptors.
Han X; Nieman MT
Thromb Res; 2020 Dec; 196():87-98. PubMed ID: 32853981
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor 4: a critical participator in inflammatory response.
Fu Q; Cheng J; Gao Y; Zhang Y; Chen X; Xie J
Inflammation; 2015 Apr; 38(2):886-95. PubMed ID: 25120239
[TBL] [Abstract][Full Text] [Related]
14. Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.
Gieseler F; Ungefroren H; Settmacher U; Hollenberg MD; Kaufmann R
Cell Commun Signal; 2013 Nov; 11():86. PubMed ID: 24215724
[TBL] [Abstract][Full Text] [Related]
15. Characterization and functional activity of thrombin receptors in the human lens.
James C; Collison DJ; Duncan G
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):925-32. PubMed ID: 15728549
[TBL] [Abstract][Full Text] [Related]
16. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
Miike S; McWilliam AS; Kita H
J Immunol; 2001 Dec; 167(11):6615-22. PubMed ID: 11714832
[TBL] [Abstract][Full Text] [Related]
17. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-activated receptors (PARs) as targets for antiplatelet therapy.
Cunningham M; McIntosh K; Bushell T; Sloan G; Plevin R
Biochem Soc Trans; 2016 Apr; 44(2):606-12. PubMed ID: 27068977
[TBL] [Abstract][Full Text] [Related]
19. PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.
McCoy KL; Traynelis SF; Hepler JR
Mol Pharmacol; 2010 Jun; 77(6):1005-15. PubMed ID: 20215560
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
